FeesSafety
Pluang+

Safety committee approves dose increase to 15 mg/kg in Entrada's Duchenne muscular dystrophy trial

Market News
18 Nov 2026, 10:00 WIB
GlobeNewsWire
View Source
Bullish
Safety committee approves dose increase to 15 mg/kg in Entrada's Duchenne muscular dystrophy trial

Entrada Therapeutics announced that an independent safety committee recommended increasing the dose to 15 mg/kg for Cohort 3 in their Phase 1/2 ELEVATE-45-201 trial targeting Duchenne muscular dystrophy. This follows the completion of Cohort 2 at 10 mg/kg, with data expected in the first half of 2027. The dose escalation aims to enhance dystrophin production and functional benefits while maintaining a convenient dosing schedule of once every six weeks. The study evaluates the safety and effectiveness of ENTR-601-45 in patients amenable to exon 45 skipping, a mutation affecting about 9% of Duchenne patients globally.

The independent safety committee's recommendation for Entrada Therapeutics' dose increase in their ELEVATE-45-201 study provides context for health sector activity. For readers following health stocks, here is Pluang's market snapshot as of Nov 18, 2026 14:12 WIB: out of 150 priced US health-sector stocks, 43 rose and 105 fell. Notable movers include XRAY at USD 8.61 with a -3.80% change and a typical hold time of 75 days, CLPT at USD 8.00 down -3.61% but with 100% buy orders and a 13-day hold, and IONS at USD 27.00 down -3.61% with 94% sell orders and a 5-day hold time.

More News

Payhawk raises $280M at $2B valuation to build AI-driven global finance system

Payhawk raises $280M at $2B valuation to build AI-driven global finance system

Payhawk secured $280 million in a Series C funding round led by Goldman Sachs Alternatives, reaching a $2 billion valuation. The company aims to develop a global AI-native financial operating system that integrates AI agents, payments, and corporate ...

Company Fundamentals
Bullish
13 minutes ago
Payhawk raises $280M in Series C led by Goldman Sachs to build AI-driven financial Operating System.

Payhawk raises $280M in Series C led by Goldman Sachs to build AI-driven financial Operating System.

Payhawk secured $280 million in a Series C funding round led by Goldman Sachs Growth, valuing the company at $2 billion. The fintech aims to develop a financial Operating System integrating AI agents, payments, and corporate controls to automate fina...

Company Fundamentals
Bullish
13 minutes ago
Trading suspended for IA Invest funds during transfer to PortfolioManager until Nov 26, 2026

Trading suspended for IA Invest funds during transfer to PortfolioManager until Nov 26, 2026

Trading in several IA Invest fund units is suspended from November 18, 2026, due to their transfer to Investeringsforeningen PortfolioManager. The suspension affects funds including Strategic Danske Aktier and Advice Capital series, and is expected t...

Company Fundamentals
Neutral
13 minutes ago
Payhawk raises $280M at $2B valuation to build AI-driven global Finance Operating System.

Payhawk raises $280M at $2B valuation to build AI-driven global Finance Operating System.

Payhawk secured $280 million in a Series C funding round led by Goldman Sachs, valuing the company at $2 billion. The capital will support Payhawk's ambition to develop a global Finance Operating System that integrates AI agents, payment infrastructu...

Company Fundamentals
Bullish
13 minutes ago
Diversified Energy buys back 370,570 shares at $13.87 average, reducing shares outstanding to 69.75M

Diversified Energy buys back 370,570 shares at $13.87 average, reducing shares outstanding to 69.75M

Diversified Energy PLC repurchased 370,570 of its common shares between November 12 and 17, 2026, at a volume-weighted average price of $13.87 per share. These shares will be cancelled, reducing the total shares outstanding to 69,752,072. This buybac...

Company Fundamentals
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App